| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.032 | 0.6 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.044 | 0.5 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.046 | 0.5 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.058 | 0.4 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.076 | 0.3 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.079 | 0.3 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.092 | 0.2 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.15 | 0.03 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.18 | 0.01 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.17 | 0.01 |